Randomized study of CGRP monoclonal antibodies for migraine
Not Applicable
- Conditions
- migraine (high frequent episodic migraine, chronic migraine, medication-overuse headach)
- Registration Number
- JPRN-jRCT1041230151
- Lead Sponsor
- Saito Ryuta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients who have been diagnosed with high frequent episodic migraine or chronic migraine (including medication-overuse headache) and have headaches for 8 or more days per month
-No intracranial disease found on head MRI/A
-18 years of age or older
-Meets the criteria for use of CGRP monoclonal antibodies
-Patients who have obtained written consent fromthe patient
Exclusion Criteria
-Patients with intracranial disease
-Patients with serious complications (liver disease, kidney disease, heart disease, lung disease, blood disease, brain disease, etc.)
-Pregnant or potentially pregnant patients
-Breastfeeding patient
-Patients who are considered as inappropriate by a head of research or research assignations
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method